ADHD Pharmacotherapy and Mortality in Individuals With ADHD

医学 药物治疗 危险系数 精神科 儿科 队列 注意缺陷多动障碍 队列研究 共病 内科学 置信区间
作者
Lin Li,Nanbo Zhu,Le Zhang,Ralf Kuja‐Halkola,Brian M. D’Onofrio,Isabell Brikell,Paul Lichtenstein,Samuele Cortese,Henrik Larsson,Zheng Chang
出处
期刊:JAMA [American Medical Association]
卷期号:331 (10): 850-850 被引量:108
标识
DOI:10.1001/jama.2024.0851
摘要

Importance: Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks of adverse health outcomes including premature death, but it is unclear whether ADHD pharmacotherapy influences the mortality risk. Objective: To investigate whether initiation of ADHD pharmacotherapy was associated with reduced mortality risk in individuals with ADHD. Design, Setting, and Participants: In an observational nationwide cohort study in Sweden applying the target trial emulation framework, we identified individuals aged 6 through 64 years with an incident diagnosis of ADHD from 2007 through 2018 and no ADHD medication dispensation prior to diagnosis. Follow-up started from ADHD diagnosis until death, emigration, 2 years after ADHD diagnosis, or December 31, 2020, whichever came first. Exposures: ADHD medication initiation was defined as dispensing of medication within 3 months of diagnosis. Main Outcomes and Measures: We assessed all-cause mortality within 2 years of ADHD diagnosis, as well as natural-cause (eg, physical conditions) and unnatural-cause mortality (eg, unintentional injuries, suicide, and accidental poisonings). Results: Of 148 578 individuals with ADHD (61 356 females [41.3%]), 84 204 (56.7%) initiated ADHD medication. The median age at diagnosis was 17.4 years (IQR, 11.6-29.1 years). The 2-year mortality risk was lower in the initiation treatment strategy group (39.1 per 10 000 individuals) than in the noninitiation treatment strategy group (48.1 per 10 000 individuals), with a risk difference of -8.9 per 10 000 individuals (95% CI, -17.3 to -0.6). ADHD medication initiation was associated with significantly lower rate of all-cause mortality (hazard ratio [HR], 0.79; 95% CI, 0.70 to 0.88) and unnatural-cause mortality (2-year mortality risk, 25.9 per 10 000 individuals vs 33.3 per 10 000 individuals; risk difference, -7.4 per 10 000 individuals; 95% CI, -14.2 to -0.5; HR, 0.75; 95% CI, 0.66 to 0.86), but not natural-cause mortality (2-year mortality risk, 13.1 per 10 000 individuals vs 14.7 per 10 000 individuals; risk difference, -1.6 per 10 000 individuals; 95% CI, -6.4 to 3.2; HR, 0.86; 95% CI, 0.71 to 1.05). Conclusions and Relevance: Among individuals diagnosed with ADHD, medication initiation was associated with significantly lower all-cause mortality, particularly for death due to unnatural causes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界的应助被老大车采纳,获得10
刚刚
可靠连虎发布了新的文献求助10
1秒前
1秒前
Pluma完成签到,获得积分10
1秒前
qwer完成签到,获得积分10
1秒前
斯文败类的应助被junge采纳,获得10
2秒前
2秒前
英吉利25发布了新的文献求助10
2秒前
无语的觅露完成签到,获得积分10
3秒前
3秒前
Nicole发布了新的文献求助10
3秒前
Hello的应助被赫赫采纳,获得10
3秒前
芳大王完成签到,获得积分10
4秒前
睡个好觉发布了新的文献求助10
4秒前
4秒前
参天小树发布了新的文献求助10
4秒前
jiusi完成签到 ,获得积分10
4秒前
DJY的应助被zyjsunye采纳,获得10
5秒前
molihuakai的应助被Jing采纳,获得10
6秒前
youth完成签到,获得积分10
6秒前
Donger完成签到 ,获得积分10
7秒前
小巧妙梦发布了新的文献求助10
7秒前
7秒前
iLL完成签到,获得积分10
7秒前
科研发布了新的文献求助10
7秒前
junge发布了新的文献求助10
8秒前
科研通AI6.3的应助被Tiana采纳,获得10
9秒前
9秒前
9秒前
羽6发布了新的文献求助10
9秒前
dde发布了新的文献求助10
9秒前
wenrui完成签到 ,获得积分10
10秒前
李健的粉丝团团长的应助被MG采纳,获得10
10秒前
yyyyyzy完成签到,获得积分10
10秒前
昏睡的咖啡完成签到,获得积分10
10秒前
10秒前
安静静静静完成签到,获得积分10
10秒前
英姑的应助被星空采纳,获得10
11秒前
iLL发布了新的文献求助10
11秒前
搜集达人的应助被daisyyy采纳,获得30
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186261
求助须知:如何正确求助?哪些是违规求助? 9574697
关于积分的说明 21837731
捐赠科研通 7783915
什么是DOI,文献DOI怎么找? 3434752
关于科研通互助平台的介绍 2559109
邀请新用户注册赠送积分活动 2481528